EXPLORATION OF THE RELATIONSHIP BETWEEN HYPOXIA AND MEASURES OF CLINICAL STATUS AND INFLAMMATION IN CHILDREN WITH CYSTIC FIBROSIS By Dr

s: 1. Urquhart DS, Laverty A, Stanojevic S, Odendaal D, Derrick G, Scrase E, Bryon M, Montgomery H, Narang I , Jaffé A. Association of nocturnal hypoxia and clinical status in childhood cystic fibrosis. Thorax 2009; 64 (Supplement 4): A114. 2. Urquhart DS, Stanojevic S, Laverty A, Montgomery H, Narang I , Jaffé A. Selection of an optimal definition of clinically-significant hypoxia in children with cystic fibrosis. Pediatr Pulmonol 2009; 44 (S10): 348-349. 3. Urquhart DS, Laverty A, Stanojevic S, Odendaal D, Derrick G, Scrase E, Bryon M, Montgomery H, Narang I , Jaffé A. Association of nocturnal hypoxia and adverse clinical status in children with cystic fibrosis – cause or effect? Pediatr Pulmonol 2009; 44 (S10): 349. 4. Urquhart DS, Field B, Bryon M, Jaffé A. Effects of lung function and exercise capacity on quality of life in CF using the United Kingdom Cystic Fibrosis Questionnaire [CFQ-UK]. Thorax 2007; 62 (Supplement 3): A103-A104. 5. Urquhart DS, Scrase E, Narang I, Montgomery H, Jaffé A. Respiratory muscle pressure measurement in children with cystic fibrosis. Thorax 2006; 61: ii97. 6. Urquhart DS, Odendaal D, Laverty A, Scrase E, Narang I, Derrick G, Montgomery H, Jaffé A. Predicting nocturnal hypoxia in children with CF. Pediatr Pulmonol 2006; 41(S29): 346-347. 7. Selvadurai H, Montgomery H, Urquhart D, Wilkes D, Schneiderman-Walker J, van Asperen P, Jaffé A. Angiotensin converting enzyme gene polymorphism and exercise capacity in children with cystic fibrosis. Pediatr Pulmonol 2006; 41(S29): 352. 8. Urquhart DS, Odendaal D, Narang I, Derrick G, Montgomery H, Jaffé A. Exercise prescription in CF – A therapeutic modality for all? Pediatr Pulmonol 2006; 41(S29): 354.